The FDA granted Breakthrough Therapy designation to a bacteriophage treatment for complicated staph bloodstream infections ahead of a planned Phase 3 trial.
FDA Grants Breakthrough Status to a Phage Treatment for Drug Resistant Staph Bloodstream Infections Ahead of Phase 3
by | Sep 15, 2026 | Uncategorized | 0 comments
Recent Comments